Your browser doesn't support javascript.
loading
Single Institutional Experience of Bladder-Preserving Trimodality Treatment for Muscle-Invasive Bladder Cancer
Journal of Korean Medical Science ; : 598-603, 2008.
Article in English | WPRIM | ID: wpr-9481
ABSTRACT
The authors designed this study to determine the clinical effectiveness of trimodality treatment, i.e., transurethral resection of a bladder tumor (TURBT) and concurrent chemoradiotherapy (CRT). Twenty patients with a muscle-invasive bladder cancer were treated by TURBT followed by concurrent cisplatin (75 mg/m(2) day), administered on weeks 1 and 4 of radiotherapy. According to residual tumor status after TURBT, patients were classified into patients with a complete TURBT group and incomplete TURBT group. Response to treatment was evaluated by restaging TURBT at 4 weeks after completing CRT (post-CRT). Fifteen patients (75%) achieved complete remission (CR) at restaging; 10 patients (50%) remained continuously free of tumor recurrence. Disease-specific and overall survivals were 51.1% and 38.6% at 5 yr post-CRT, respectively. Of 16 patients in the complete TURBT group, 14 patients (87.5%) achieved CR, which was significantly different from that observed in the incomplete TURBT group, in which only 1 (25%) of 4 patients achieved CR (p=0.032). Five- year disease-specific and overall survivals were 71.6% and 53.5%, respectively. Ten patients (90.9%) maintained their own bladder among the 11 surviving patients. Trimodality treatment was found to be an effective treatment in patients who underwent complete TURBT for a muscle-invasive bladder cancer.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Urinary Bladder Neoplasms / Cisplatin / Salvage Therapy / Combined Modality Therapy / Muscle Neoplasms / Neoplasm Invasiveness Limits: Female / Humans / Male Language: English Journal: Journal of Korean Medical Science Year: 2008 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Urinary Bladder Neoplasms / Cisplatin / Salvage Therapy / Combined Modality Therapy / Muscle Neoplasms / Neoplasm Invasiveness Limits: Female / Humans / Male Language: English Journal: Journal of Korean Medical Science Year: 2008 Type: Article